Novo Nordisk Rebrands as 'Novo' With New 'Lasting Health Starts Now' Tagline and 'The Novo Way' Culture Framework Ahead of September 21 London Capital Markets Day
Novo Nordisk (NYSE: NVO; Copenhagen: NOVO-B) announced Monday September 14, 2026 the rollout of its updated corporate identity: the operating brand is now simply 'Novo' with the tagline 'Lasting health starts now' plus a new culture framework called 'The Novo Way,' anchored by a refreshed version of the historic Apis bull logo. The legal entity name Novo Nordisk A/S is unchanged, and the NYSE ticker (NVO) and Copenhagen (NOVO-B) tickers remain. CEO Mike Doustdar is expected to detail the strategic backing for the rebrand at the September 21 Capital Markets Day in London — the first Novo Capital Markets Day since Doustdar was named CEO and following the Morgan Stanley Underweight downgrade on Friday September 11 (DKK 250 target, semaglutide patent cliff concerns), Barclays trim from DKK 310 to DKK 300, and HSBC target raise to DKK 320 (Hold). The rebrand pairs with an operational push to regain U.S. Wegovy/Ozempic prescription share against Lilly's tirzepatide franchise, plus the September 16 Anthropic Claude Science R&D collaboration, September 7 STEP Young pediatric semaglutide win, and September 4-7 ziltivekimab HERMES + ATHENA heart-failure trial terminations that have narrowed the non-GLP-1 diversification story.